AMRN Amarin Corp Plc
Price (delayed)
$0.44
Market cap
$182.24M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.2
Enterprise value
$68.63M
Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its
Highlights
AMRN's quick ratio is up by 33% year-on-year and by 12% since the previous quarter
AMRN's debt is down by 12% year-on-year and by 6% since the previous quarter
AMRN's net income has plunged by 109% from the previous quarter and by 39% YoY
The company's EPS has shrunk by 100% QoQ and by 33% YoY
Key stats
What are the main financial stats of AMRN
Market
Valuations
Earnings
Shares outstanding
414.19M
Market cap
$182.24M
Enterprise value
$68.63M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.37
Price to sales (P/S)
0.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.3
Revenue
$228.61M
Gross profit
$81.38M
Operating income
-$91.8M
Net income
-$82.18M
EBIT
-$77.19M
EBITDA
-$74.18M
Free cash flow
-$31.02M
Per share
Balance sheet
Liquidity
EPS
-$0.2
EPS diluted
-$0.2
Free cash flow per share
-$0.08
Book value per share
$1.18
Revenue per share
$0.56
TBVPS
$1.63
Total assets
$685.35M
Total liabilities
$199.17M
Debt
$7.72M
Equity
$486.18M
Working capital
$415.45M
Debt to equity
0.02
Current ratio
3.31
Quick ratio
2.32
Net debt/EBITDA
1.53
Margins
Efficiency
Dividend
EBITDA margin
-32.4%
Gross margin
35.6%
Net margin
-35.9%
Operating margin
-40.2%
Return on assets
-10.9%
Return on equity
-15.5%
Return on invested capital
-21.4%
Return on capital employed
-15.3%
Return on sales
-33.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AMRN stock price
How has the Amarin stock price performed over time
Intraday
-1.81%
1 week
-4.14%
1 month
-18.8%
1 year
-50.11%
YTD
-9.28%
QTD
-1.81%
Financial performance
How have Amarin's revenue and profit performed over time
Revenue
$228.61M
Gross profit
$81.38M
Operating income
-$91.8M
Net income
-$82.18M
Gross margin
35.6%
Net margin
-35.9%
AMRN's operating margin has dropped by 120% since the previous quarter and by 83% year-on-year
AMRN's net margin has dropped by 120% since the previous quarter and by 86% year-on-year
AMRN's net income has plunged by 109% from the previous quarter and by 39% YoY
AMRN's operating income has dropped by 108% since the previous quarter and by 36% year-on-year
Growth
What is Amarin's growth rate over time
Valuation
What is Amarin stock price valuation
P/E
N/A
P/B
0.37
P/S
0.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.3
The company's EPS has shrunk by 100% QoQ and by 33% YoY
AMRN's P/B is 78% below its 5-year quarterly average of 1.7 and 24% below its last 4 quarters average of 0.5
The equity has declined by 12% year-on-year and by 9% since the previous quarter
The P/S is 61% less than the 5-year quarterly average of 2.1 and 26% less than the last 4 quarters average of 1.1
The revenue is down by 26% year-on-year and by 5% since the previous quarter
Efficiency
How efficient is Amarin business performance
The company's return on sales has shrunk by 160% QoQ and by 93% YoY
The ROIC has shrunk by 143% QoQ and by 41% YoY
Amarin's ROA has plunged by 118% from the previous quarter and by 56% YoY
AMRN's ROE has plunged by 115% from the previous quarter and by 48% YoY
Dividends
What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AMRN.
Financial health
How did Amarin financials performed over time
AMRN's quick ratio is up by 33% year-on-year and by 12% since the previous quarter
AMRN's total liabilities is down by 29% year-on-year and by 9% since the previous quarter
AMRN's debt is 98% smaller than its equity
AMRN's debt is down by 12% year-on-year and by 6% since the previous quarter
The equity has declined by 12% year-on-year and by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.